The Baobao Xingye Standard & Poor's Oil & Gas Upstream Index ** mainly adopts a rigorous indexed investment strategy to achieve effective tracking of the S&P Oil & Gas Upstream stock index. The investment in the S&P Oil & Gas Upstream Equity Index constituent stocks and constituent stocks is not less than 80% of the net asset value.
As the contradiction between supply has become increasingly prominent, especially since the 1980s, there has been no major global crude oil reserves discovered, but the global economic development has brought rising demand for oil and gas energy, resulting in a clear long-term upward trend in energy prices as a non-renewable energy source. Scarcity determines its high investment value. The S&P Upstream Oil Stock Index is one of the selected sub-industry indexes based on the S&P market index. This index includes oil and gas upstream industry companies listed on major U.S. exchanges, such as ExxonMobil, Chevron, etc. The world-renowned oil companies are on the list. The index's trend is well-matched with oil prices, and it shows a high degree of flexibility relative to rising oil prices. In the oil price increase interval from July 30, 2010 to April 8, 2011, WTI crude oil prices rose by 31.28%, while the S&P Oil & Gas Upstream Index rose by 57.69% over the same period. In the long run, the S&P Oil & Gas Upstream Index has seen an astonishing increase. From 2001 to 2010, the index has risen by 378%, which has brought lucrative returns to investors investing in the index.
Mr. Yu Bainian, Ph.D., is appointed as manager, and holds a doctorate degree in economics. He has 8 years experience in the securities industry. He has worked in investment and financial engineering model development, asset allocation, and industry research for the Apex Investment Advisory team at BConnect Australia. He joined the Fortune 500 Company in June 2007 as a senior quantitative analyst in the Financial Engineering Department. He has been a senior analyst in the Overseas Investment Department since August 2008. He was a Fortune SG Overseas China Growth Equity Securities from March 2009 to March 2011. Investment Manager Assistant Manager and Senior Analyst. Since March 2011, he has been the manager of QDII** in the mature market of Fortune SG.
Based on the above analysis, we believe that as a non-renewable energy source, oil and natural gas is a tight supply and demand commodity category, and the tight supply and demand determines the long-term bullishness of its prices, and its investment prospects are good. Since the Baobao Xingye S&P Upstream Oil Index** is an American stock index-type securities investment**, it is a product with a higher expected risk, and a growth investor can properly participate in the investment.
Yongyue cryo vials are made of medical grade polypropylene (PP) and have no endotoxin. They are disposable laboratory consumables specially used for storing biological samples.
The anti-slip texture of the cap and body is easy to screw cap.
The tube cap has an O-ring built-in gasket to prevent liquid leakage.
The cryo tube is suitable for ultra-low temperature refrigerators, and the tolerance temperature is -86~121 °C, and it can be repeatedly frozen and thawed.
In the gaseous state of liquid nitrogen, it can withstand low temperature to -167 ℃.
According to different requirements, there are ordinary grade and PCR grade. PCR grade products are free of DNase, RNase, endotoxin and foreign DNA. Sterilized by gamma irradiation, sterile.
Cryo Vials,Cryovial 2ml,Cryotube 1.8 ml,Cryogenic Vials,0.5 ml Cryogenic Vials
Yong Yue Medical Technology(Kunshan) Co.,Ltd , https://www.yongyuepcr.com